FAKTOR-OPTIONSSCHEIN - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Börse Stuttgart 12:54:19 18/05/2024 am IST | ||
| 8.01 EUR | +7.66% |
|
| Current month | +11.87% | ||
| 1 month | +14.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 8.01 | +7.66% |
| 16/24/16 | 7.44 | -10.58% |
| 15/24/15 | 8.32 | +7.22% |
| 14/24/14 | 7.76 | +5.29% |
| 13/24/13 | 7.37 | -4.53% |
Delayed Quote Börse Stuttgart
Last update May 18, 2024 at 12:54 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MG157M |
| ISIN | DE000MG157M2 |
| Date issued | 27/03/2024 |
| Strike | 42.34 € |
| Maturity | Unlimited |
| Parity | 1.1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.34 € |
|---|---|
| Lowest since issue | 6.26 € |
| Spread | 0.29 € |
| Spread % | 3.49% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
51.2
EUR
Average target price
52.24
EUR
Spread / Average Target
+2.03%
- Stock Market
- Certificates
- Certificat